A new and powerful Australian artificial intelligence model can comb through data from confidential pharmaceutical trials – both failed and successful – to help big pharma companies avoid wasting their resources on already investigated dead ends. Australian start-up Qubigen developed the AI algorithm that can learn from confidential medical, chemical and biological data and help …read more